Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Dorothy Nicholas

Administrative Assistant, Office of the Vice-Provost (Enterprise)

T: 020 3108 5072
E: d.nicholas@ucl.ac.uk

Dorothy joined the Office of the Vice-Provost (Enterprise) in 2013. As well as being responsible for general financial administration for the team, Dorothy provides support to the KE Manager in collating the quarterly KPIs and provides general administrative support to the Executive Assistant to the Vice-Provost (Enterprise), covering her role in her absence, and to the Vice-Provost (Enterprise).

Before joining UCL Dorothy worked in research and marketing, supporting forensic accounting teams at Deloitte and Smith & Williamson.